This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wagner, W. R. Articles by Griffith, B. P. Search for Related Content PubMed PubMed Citation Articles by Wagner, W. R. Articles by Griffith, B. P.

Circulation, Vol 88, 2023-2029, Copyright © 1993 by American Heart Association

ARTICLES

Evaluation of bioprosthetic valve-associated thrombus in ventricular assist device patients

WR Wagner, PC Johnson, RL Kormos and BP Griffith
Artificial Heart and Lung Program, University of Pittsburgh, PA.

BACKGROUND. Thromboembolic events may be related to thrombotic deposition on prosthetic valves. In a left ventricular assist device (LVAD) that contains two porcine pericardial bioprosthetic valves in addition to significant associated biomaterial placement, this may be particularly true. Thrombotic deposits on valves removed from LVADs at autopsy or heart transplantation were scored to determine (1) the nature and location of valvular deposition, (2) whether deposition was related to thromboembolic events, (3) correlations between deposition and patient hemodynamic and coagulation parameters, and (4) implant time dependency. METHODS AND RESULTS. Novacor LVADs were implanted in 23 patients as a bridge to transplantation for 1 to 303 days. Photographs of the concave (downstream) and convex (upstream) side of the inflow and outflow valve were made at explant and later scored for (1) total thrombus area (10 = equivalent of cusp area), (2) percent of cusp area occupied by solid thrombus, (3) thrombus color (10 = dark red, 0 = white), and (4) average percent of valve strut height involved with thrombus (from a side view). The inflow valve was shown to have heavier and redder deposition than the outflow valve. This was also true for the concave versus the convex side. Heaviest deposition was seen on the inflow valve concave side, which rests within the LVAD pumping sac and may be subject to poor convection. Patients with neurological thromboembolic events (8/23) during implantation had heavier deposition on the inflow valve concave side (5.7 +/- 2.7 versus 4.6 +/- 2.2, P < .05). Pump volumetric output was also found to negatively correlate with thrombus area on this valve and side (r = - .61, P = .002). Platelet release (platelet factor 4) was correlated with thrombus involvement on the upstream (convex) side of the inflow valve (r = .82, P = .002). No significant dependence of deposition on the implant time was found. CONCLUSIONS. Valve thrombus deposition was related to thromboembolic events. Pump volumetric output and platelet release were found to be related to deposition. These results may have implications for the role of hemodynamics and platelet activation in thromboembolism associated with prosthetic valve placement in general.

This article has been cited by other articles:

				D. G. Nabavi, J. Stockmann, C. Schmid, M. Schneider, D. Hammel, H. H. Scheld, and E. B. Ringelstein Doppler microembolic load predicts risk of thromboembolic complications in Novacor patients J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 160 - 167. [Abstract] [Full Text] [PDF]

				S. Itescu and R. John Interactions between the recipient immune system and the left ventricular assist device surface: immunological and clinical implications Ann. Thorac. Surg., June 1, 2003; 75(90060): S58 - 65. [Abstract] [Full Text] [PDF]

				M. N. Kavarana, M. S. Pessin-Minsley, J. Urtecho, K. A. Catanese, M. Flannery, M. C. Oz, and Y. Naka Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem Ann. Thorac. Surg., March 1, 2002; 73(3): 745 - 750. [Abstract] [Full Text] [PDF]

				H. J. Ankersmit, G. Wieselthaler, B. Moser, S. Gerlitz, G. Roth, G. Boltz-Nitulescu, and E. Wolner Transitory immunologic response after implantation of the DeBakey VAD continuous-axial-flow pump J. Thorac. Cardiovasc. Surg., March 1, 2002; 123(3): 557 - 561. [Abstract] [Full Text] [PDF]

				M. N. Kavarana, D. N. Helman, M. R. Williams, A. Barbone, J. A. Sanchez, E. A. Rose, M. C. Oz, M. Milbocker, and R. T. V. Kung Circulatory support with a direct cardiac compression device: A less invasive approach with the AbioBooster device J. Thorac. Cardiovasc. Surg., October 1, 2001; 122(4): 786 - 787. [Full Text] [PDF]

				V. Rao, J. P. Slater, N. M. Edwards, Y. Naka, and M. C. Oz Surgical management of valvular disease in patients requiring left ventricular assist device support Ann. Thorac. Surg., May 1, 2001; 71(5): 1448 - 1453. [Abstract] [Full Text] [PDF]

				D. Gagnon, M. Petty, and J. R Lahpor HeartMate(R) family of left ventricular assist systems Perfusion, July 1, 2000; 15(4): 345 - 354. [PDF]

				C. Schmid, M. Wilhelm, M. Rothenburger, D. Nabavi, M. C. Deng, D. Hammel, and H. H. Scheld Effect of high dose platelet inhibitor treatment on thromboembolism in Novacor patients Eur. J. Cardiothorac. Surg., March 1, 2000; 17(3): 331 - 335. [Abstract] [Full Text] [PDF]

				C. R. Wilhelm, J. Ristich, L. E. Knepper, R. Holubkov, S. R. Wisniewski, R. L. Kormos, and W. R. Wagner Measurement of Hemostatic Indexes in Conjunction With Transcranial Doppler Sonography in Patients With Ventricular Assist Devices Stroke, December 1, 1999; 30(12): 2554 - 2561. [Abstract] [Full Text] [PDF]

				D. R. Gross Concerning thromboembolism associated with left ventricular assist devices Cardiovasc Res, April 1, 1999; 42(1): 45 - 47. [Full Text] [PDF]

				C. Schmid, M. Weyand, D. G. Nabavi, D. Hammel, M. C. Deng, E. B. Ringelstein, and H. H. Scheld Cerebral and Systemic Embolization During Left Ventricular Support With the Novacor N100 Device Ann. Thorac. Surg., June 1, 1998; 65(6): 1703 - 1710. [Abstract] [Full Text] [PDF]

				MehmetC. Oz, M. Argenziano, K. A. Catanese, M. T. Gardocki, D. J. Goldstein, R. C. Ashton, A. C. Gelijns, E. A. Rose, and H. R. Levin Bridge Experience With Long-term Implantable Left Ventricular Assist Devices: Are They an Alternative to Transplantation? Circulation, April 1, 1997; 95(7): 1844 - 1852. [Abstract] [Full Text]

				J. P. Slater, E. A. Rose, H. R. Levin, O. H. Frazier, J. K. Roberts, A. D. Weinberg, and M. C. Oz Low Thromboembolic Risk Without Anticoagulation Using Advanced-Design Left Ventricular Assist Devices Ann. Thorac. Surg., November 1, 1996; 62(5): 1321 - 1327. [Abstract] [Full Text]